Latest News and Press Releases
Want to stay updated on the latest news?
-
RxSight allegedly overstated product demand and hid adoption challenges that hurt sales, leading to slashed 2025 guidance and a 38% stock drop.
-
LOS ANGELES, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
Allegedly, RxSight hid adoption issues and overstated demand, later slashing guidance and revealing weak sales, causing its stock to drop nearly 38%.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options ...
-
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between May 7, 2024 and July...
-
RxSight, Inc. investors that lost money are notified to contact BFA Law before the September 22, 2025 securities fraud class action deadline.
-
RxSight allegedly overstated product demand while facing adoption issues, then cut guidance and revealed weak sales, causing shares to plunge 38%.
-
RxSight, Inc. investors that lost money are notified to contact BFA Law before the September 22, 2025 securities fraud class action deadline.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or...
-
RxSight allegedly overstated demand and hid adoption issues; after slashing 2025 guidance on July 8, 2025, shares plunged nearly 38%.